title: Outcomes of a pharmacist-managed medication refill program.
abstract: OBJECTIVE
  To compare the completeness of medication and blood pressure monitoring among patients requesting medication refills through the pharmacist-managed medication refill and laboratory monitoring program (MRLMP) versus usual care.
  
  
  METHODS
  Quasiexperimental study.
  
  
  METHODS
  Kaiser Permanente Colorado between November 2011 and June 2012.
  
  
  METHODS
  Patients requesting chronic medication prescription refills.
  
  
  METHODS
  Community pharmacists managed the refill authorization request (RAR) process at the intervention site. For each RAR, the pharmacist reviewed patient medication monitoring needs and ordered laboratory test(s) or a clinic visit, as needed, before approval.
  
  
  METHODS
  For medications due for laboratory or blood pressure monitoring at the time of the RAR, the 1-month rate of attaining complete monitoring was compared between groups. Pharmacist, primary care physician (PCP), and patient satisfaction and PCP time saved also were compared.
  
  
  RESULTS
  3,797 RARs for MRLMP-eligible medications were approved in the month following MRLMP implementation in the intervention and control clinics. The intervention and control groups converted 49% and 29% of medications due for laboratory monitoring ( P < 0.001) and 56% and 33% of those due for blood pressure monitoring, respectively ( P = 0.020). The intervention group PCPs were more likely than control group PCPs to report being "very satisfied" with the RAR process (80% vs. 27%, P = 0.015) and spent fewer minutes per day on refill requests (mean 17 vs. 23, P = 0.049). The intervention group pharmacists reported higher job satisfaction (mean index score 22 vs. 18, P = 0.024), and intervention group patients reported higher satisfaction with the "readiness" of their prescription when they came to pick it up (91% vs. 80%, P = 0.004).
  
  
  CONCLUSIONS
  A pharmacist-managed MRLMP resulted in improved process-related outcomes. Future studies should assess clinical outcomes.
authors.forename: Sarah J
authors.initials: SJ
authors.lastname: Billups
authors.forename: Thomas
authors.initials: T
authors.lastname: Delate
authors.forename: Carey
authors.initials: C
authors.lastname: Newlon
authors.forename: Sarah
authors.initials: S
authors.lastname: Schwiesow
authors.forename: Renee
authors.initials: R
authors.lastname: Jahnke
authors.forename: Ann
authors.initials: A
authors.lastname: Nadrash
mesh_terms: D001795:Blood Pressure Determination / Q000379:methods; D003120:Colorado; D003157:Community Pharmacy Services / Q000458:organization & administration* / Q000706:statistics & numerical data; D016903:Drug Monitoring / Q000379:methods; D005500:Follow-Up Studies; D006801:Humans; D007588:Job Satisfaction; D017060:Patient Satisfaction; D010595:Pharmacists / Q000458:organization & administration*; D055553:Prescription Drugs / Q000008:administration & dosage*; D011320:Primary Health Care / Q000458:organization & administration; D024382:Professional Role; D013997:Time Factors
chemical_list: D055553:Prescription Drugs